BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1934983)

  • 21. Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis.
    Chudwin DS; Strub M; Golden HE; Frey C; Richmond GW; Luskin AT
    Ann Allergy; 1986 Aug; 57(2):133-4. PubMed ID: 3740556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labeling changes for arthritis drug.
    FDA Consum; 2002; 36(5):6. PubMed ID: 12412538
    [No Abstract]   [Full Text] [Related]  

  • 24. Salicylates in the treatment of arthritic disease. How safe and effective?
    Altman RD
    Postgrad Med; 1988 Nov; 84(6):206-10. PubMed ID: 3054846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nonsteroidal anti-inflammatory drugs].
    Kawai S
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():178-84. PubMed ID: 23156505
    [No Abstract]   [Full Text] [Related]  

  • 26. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
    Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220
    [No Abstract]   [Full Text] [Related]  

  • 27. [Upper gastrointestinal hemorrhage caused by anti-inflammatory agents].
    Duhamel C; Czernichow P; Dechelotte P; Ducrotte P; Lerebours E; Colin R
    Gastroenterol Clin Biol; 1989 Mar; 13(3):239-44. PubMed ID: 2786480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative experimental studies in animals and humans on gastrointestinal blood loss following antirheumatic pharmacotherapy (author's transl)].
    Palme G; Koeppe P
    Arzneimittelforschung; 1978; 28(3):426-8. PubMed ID: 26360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
    Graham DY
    Aliment Pharmacol Ther; 2007 Feb; 25(3):345-6; author reply 346-7. PubMed ID: 17217449
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-dose aspirin: protection from the panacea.
    Guda N; Vakil N
    Am J Gastroenterol; 2002 Dec; 97(12):3202-3. PubMed ID: 12492214
    [No Abstract]   [Full Text] [Related]  

  • 34. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2005 Aug; 22(4):285-9. PubMed ID: 16097994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unknown intake of nonsteroidal anti-inflammatory drugs and digestive bleeding: clinical and drug assay assessment.
    de Korwin JD; Lapicque F; Kaletka C; Tréchot P; Netter P
    Am J Gastroenterol; 1993 Aug; 88(8):1298-9. PubMed ID: 8338116
    [No Abstract]   [Full Text] [Related]  

  • 36. An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals.
    Papich MG
    Vet Clin North Am Small Anim Pract; 2008 Nov; 38(6):1243-66, vi. PubMed ID: 18954683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 39. Ototoxicity associated with salicylates. A brief review.
    Brien JA
    Drug Saf; 1993 Aug; 9(2):143-8. PubMed ID: 8397891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serious gastrointestinal events from low dose analgesic use.
    Tarone RE; Lipworth L; McLaughlin JK
    J Rheumatol; 2004 May; 31(5):1008-9; author reply 1010-1. PubMed ID: 15124269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.